Indication
Skin and Subcutaneous Tissue Bacterial Infections
2 clinical trials
4 products
Clinical trial
Phase 2, Double-Blind, Randomized, Multicenter, Parallel, Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection in AdultsStatus: Completed, Estimated PCD: 2020-09-28
Product
VancomycinProduct
TNP-2092Clinical trial
Integrating Personal and Household Environmental Hygiene Measures to Prevent Methicillin-Resistant Staphylococcus Aureus InfectionStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Product
ChlorhexidineProduct
Mupirocin